Security key
092667104
Strata Critical Medical, Inc. - Class A Common Stock, $0.0001 par value per share (SRTA)
CUSIP: 092667104
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Class A Common Stock, $0.0001 par value per share
- Total 13F shares
- 53,418,084
- Total 13F value
- $281,377,060
- Share change
- -2,438,871
- Put/Call ratio
- 43%
- SEC-reported price per share
- $5.27
- Number of holders
- 139
- Value change
- -$12,023,155
- Number of buys
- 80
- Number of sells
- 54
- Shares outstanding
- 88,033,333
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
139
Top holders
10
SRTA full security history
Ownership snapshot
Full 13F holder table
Strata Critical Medical, Inc. SEC filings
Strata Critical Medical, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SRTA - Strata Critical Medical, Inc. - Class A Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Steele ExpCo Holdings, LLC
Disclosed value leader
Steele ExpCo Holdings, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 9%
13D/G row: Steele ExpCo Holdings, LLC
Showing 1-6 of 15 holder rows.
Quick read
Steele ExpCo Holdings, LLC leads the comparable SEC ownership view at 9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Steele ExpCo Holdings, LLC's linked filing trail.
Comparable ownership
Top 5
Steele ExpCo Holdings, LLC
9%
Third Point LLC
5.8%
Northern Right Capital Management...
5.1%
BlackRock, Inc.
5.1%
ARK Investment Management LLC
3.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Steele ExpCo Holdings, LLC |
13D/G
|
9%
|
$40,248,840
7,923,000 shares
|
$0 | 30 Jun 2026 |
| Third Point LLC |
13D/G
13F
Company
|
5.8%
|
$25,300,000
5,000,000 shares
|
$0 | 30 Sep 2025 |
| Northern Right Capital Management, L.P. |
13D/G
13F
Company
|
5.1%
|
$28,456,580
4,398,235 shares
|
$0 | 11 Jun 2026 |
| BlackRock, Inc. |
13D/G
13F
Company
|
5.1%
|
$21,091,147
4,384,945 shares
|
+$760,084 | 31 Dec 2025 |
| ARK Investment Management LLC |
13F
13D/G
Company
|
3.2%
from 13D/G
|
$31,163,087
7,455,284 shares
|
— | 31 Mar 2026 |
| Louis R. Verdetto |
3/4/5
CEO Keystone Perfusion Service
|
1.4%
|
$6,456,727
1,266,025 shares
|
— | 02 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
139
Shares
53,418,084
Rows available
139
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
125
Q2 2026 holders
139
Holder diff
14
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|